Early breast cancer. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy13

Breast Axilla Cell Line, Tumor Nipples Lymph Nodes Neoplastic Cells, Circulating MCF-7 Cells Tumor Cells, Cultured Mammary Glands, Human Surgical Flaps Neoplastic Stem Cells Ovary Epithelial Cells

Organisms2

Mice, Nude Mice, SCID

Diseases43

Breast Neoplasms Carcinoma, Ductal, Breast Lymphatic Metastasis Neoplasm Recurrence, Local Neoplasms, Hormone-Dependent Carcinoma, Lobular Neoplasm Metastasis Amenorrhea Carcinoma, Intraductal, Noninfiltrating Neoplasm Invasiveness Breast Diseases Carcinoma Neoplasms, Second Primary Carcinoma in Situ Neoplastic Cells, Circulating Breast Neoplasms, Male Lethargy Disease Progression Genetic Predisposition to Disease Bone Neoplasms Mammary Neoplasms, Experimental Ovarian Neoplasms Pregnancy Complications, Neoplastic Fibrocystic Breast Disease Lung Neoplasms Neoplasms Radiation Injuries Prostatic Neoplasms Recurrence Carcinoma, Ductal Colonic Neoplasms Stomach Neoplasms Cell Transformation, Neoplastic Triple Negative Breast Neoplasms Neovascularization, Pathologic Inflammatory Breast Neoplasms Adenocarcinoma Pancreatic Neoplasms Fibroadenoma Uterine Cervical Neoplasms Neoplasms, Basal Cell Neoplasms, Radiation-Induced Colorectal Neoplasms

Chemicals and Drugs57

Tamoxifen Antineoplastic Agents, Hormonal Aromatase Inhibitors Receptors, Estrogen Nitriles Triazoles Receptor, erbB-2 Receptors, Progesterone Epirubicin Goserelin Cyclophosphamide Tumor Markers, Biological Anthracyclines Fluorouracil Antineoplastic Agents Methotrexate Taxoids Antibodies, Monoclonal, Humanized Estrogen Antagonists Neoplasm Proteins Keratin-19 Selective Estrogen Receptor Modulators Doxorubicin Estrogen Receptor Modulators Ki-67 Antigen Diphosphonates Bone Density Conservation Agents Toremifene Bridged Compounds Androstadienes Antibodies, Monoclonal RNA, Messenger Paclitaxel Estrogen Receptor alpha Estrogens Technetium Tc 99m Sulfur Colloid BRCA2 Protein BRCA1 Protein Deoxycytidine Antibiotics, Antineoplastic DNA, Neoplasm Vinblastine Estradiol RNA, Small Interfering Tumor Suppressor Protein p53 Imidazoles Receptor, Epidermal Growth Factor Tumor Suppressor Proteins RNA, Neoplasm Cancer Vaccines Antigens, Neoplasm Anticarcinogenic Agents Antigens, CD24 Mucin-1 Transcription Factors MicroRNAs DNA-Binding Proteins

Analytical, Diagnostic and Therapeutic Techniques and Equipment86

Chemotherapy, Adjuvant Mastectomy Mastectomy, Segmental Neoplasm Staging Prognosis Disease-Free Survival Antineoplastic Combined Chemotherapy Protocols Survival Analysis Mammography Early Detection of Cancer Radiotherapy, Adjuvant Follow-Up Studies Sentinel Lymph Node Biopsy Combined Modality Therapy Treatment Outcome Risk Factors Lymph Node Excision Mammaplasty Survival Rate Prospective Studies Mastectomy, Modified Radical Retrospective Studies Immunohistochemistry Clinical Trials as Topic Multivariate Analysis Randomized Controlled Trials as Topic Predictive Value of Tests Neoadjuvant Therapy Risk Assessment Gene Expression Profiling Kaplan-Meier Estimate Proportional Hazards Models Early Diagnosis Mastectomy, Radical Radiotherapy Risk Drug Administration Schedule Incidence Reverse Transcriptase Polymerase Chain Reaction Neoplasm Grading Cohort Studies Odds Ratio Sensitivity and Specificity Case-Control Studies Breast Self-Examination Mammary Neoplasms, Experimental Biopsy, Needle Xeromammography False Negative Reactions Questionnaires Radiotherapy Dosage Logistic Models Reproducibility of Results Dose Fractionation Xenograft Model Antitumor Assays Blotting, Western Pilot Projects Registries Intraoperative Care Double-Blind Method Ultrasonography, Mammary Neoplasm Transplantation Surgical Flaps Transplantation, Heterologous Oligonucleotide Array Sequence Analysis Feasibility Studies Analysis of Variance SEER Program Tissue Array Analysis Tumor Burden Breast Implants Patient Selection Mass Screening Research Design Transfection Markov Chains Biopsy Polymerase Chain Reaction Confidence Intervals Immunoenzyme Techniques Genetic Testing Drug Screening Assays, Antitumor Molecular Targeted Therapy Estrogen Replacement Therapy Gene Knockdown Techniques In Situ Hybridization, Fluorescence

Psychiatry and Psychology4

Lethargy Breast Feeding Breast Self-Examination Decision Making

Phenomena and Processes47

Postmenopause Premenopause Gene Expression Regulation, Neoplastic Menopause Time Factors Risk Genes, BRCA1 Odds Ratio Genetic Predisposition to Disease Breast Feeding Sensitivity and Specificity Drug Resistance, Neoplasm Cell Proliferation Genes, BRCA2 Genes, erbB-2 Mutation Dose-Response Relationship, Drug Apoptosis Signal Transduction Cell Movement Cell Division Genotype Germ-Line Mutation Down-Regulation Polymorphism, Genetic DNA Methylation Promoter Regions, Genetic Cell Growth Processes Gene Amplification Transfection Markov Chains Cell Cycle RNA Interference Parity Up-Regulation Gene Silencing Cell Survival Gene Expression Genes, Tumor Suppressor Phenotype Genes, Neoplasm Phosphorylation Base Sequence Epithelial-Mesenchymal Transition Genes, p53 Alleles Bone Density

Disciplines and Occupations3

Immunohistochemistry Research Design Medical Oncology

Anthropology, Education, Sociology and Social Phenomena2

Quality of Life National Cancer Institute (U.S.)

Humanities1

Quality of Life

Information Science6

Survival Rate Incidence Questionnaires Registries SEER Program Base Sequence

Named Groups2

Survivors European Continental Ancestry Group

Health Care42

Disease-Free Survival Survival Analysis Follow-Up Studies Treatment Outcome Risk Factors Survival Rate Prospective Studies Retrospective Studies Clinical Trials as Topic Multivariate Analysis Randomized Controlled Trials as Topic Predictive Value of Tests Risk Assessment Age Factors Kaplan-Meier Estimate Proportional Hazards Models Risk Incidence Cohort Studies Odds Ratio Sensitivity and Specificity Case-Control Studies Questionnaires Logistic Models Reproducibility of Results Radiation Injuries Cost-Benefit Analysis Pilot Projects Registries Intraoperative Care Double-Blind Method Feasibility Studies Analysis of Variance SEER Program Patient Selection Mass Screening Markov Chains Confidence Intervals Parity Practice Guidelines as Topic Genetic Testing National Cancer Institute (U.S.)

Geographicals3

United States Great Britain China

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Breast Neoplasms Chemotherapy, Adjuvant Breast Tamoxifen Antineoplastic Agents, Hormonal Aromatase Inhibitors Receptors, Estrogen Carcinoma, Ductal, Breast Mastectomy Nitriles Mastectomy, Segmental Triazoles Receptor, erbB-2 Axilla Postmenopause Premenopause Neoplasm Staging Receptors, Progesterone Prognosis Epirubicin Disease-Free Survival Goserelin Lymphatic Metastasis Neoplasm Recurrence, Local Antineoplastic Combined Chemotherapy Protocols Cyclophosphamide Tumor Markers, Biological Neoplasms, Hormone-Dependent Carcinoma, Lobular Neoplasm Metastasis Survival Analysis Anthracyclines Mammography Early Detection of Cancer Amenorrhea Radiotherapy, Adjuvant Carcinoma, Intraductal, Noninfiltrating Fluorouracil Follow-Up Studies Sentinel Lymph Node Biopsy Combined Modality Therapy Antineoplastic Agents Treatment Outcome Neoplasm Invasiveness Cell Line, Tumor Gene Expression Regulation, Neoplastic Breast Diseases Menopause Risk Factors Lymph Node Excision Mammaplasty Survival Rate Carcinoma Nipples Prospective Studies Lymph Nodes Methotrexate Neoplasms, Second Primary Taxoids Mastectomy, Modified Radical Antibodies, Monoclonal, Humanized Retrospective Studies Immunohistochemistry Clinical Trials as Topic Estrogen Antagonists Multivariate Analysis Neoplasm Proteins Randomized Controlled Trials as Topic Carcinoma in Situ Time Factors Keratin-19 Predictive Value of Tests Neoadjuvant Therapy Neoplastic Cells, Circulating Breast Neoplasms, Male Risk Assessment Gene Expression Profiling Age Factors Lethargy Selective Estrogen Receptor Modulators Doxorubicin Estrogen Receptor Modulators Ki-67 Antigen Kaplan-Meier Estimate Proportional Hazards Models Early Diagnosis Mastectomy, Radical Radiotherapy Risk Genes, BRCA1 Drug Administration Schedule Diphosphonates Bone Density Conservation Agents Incidence Reverse Transcriptase Polymerase Chain Reaction Toremifene Disease Progression Bridged Compounds Neoplasm Grading MCF-7 Cells

No FAQ available that match "early breast cancer"